Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dr. Martens Plc (GB:DOCS)
LSE:DOCS
Holding GB:DOCS?
Track your performance easily
See the Price Targets and Ratings of:
DOCS Analyst Ratings
Hold
0 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DOCS Stock 12 Month Forecast
Average Price Target
76.33p
▲(29.26% Upside)
| Highest Price Target85.00p | Average Price Target76.33p | Lowest Price Target64.00p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
Upgraded
11/14/24
RBC Capital
Reiterated
10/23/24
Barclays
Reiterated
10/01/24
Deutsche Bank
0.65p→75p
Hold
27.01%
Upside
Reiterated
05/31/24
Dr. Martens Plc (DOCS:LN) PT Raised to GBP0.75 at Deutsche BankDeutsche Bank analyst Alison Lygo raised the price target on Dr. Martens Plc (DOCS:LN) to GBP0.75 (from GBP0.65) while maintaining a Hold rating.
HSBC
95p→70p
Hold
18.54%
Upside
Reiterated
04/26/24
Dr. Martens Plc (DOCS:LN) PT Lowered to GBP0.70 at HSBCHSBC analyst Doriana Russo lowered the price target on Dr. Martens Plc (DOCS:LN) to GBP0.70 (from GBP0.95) while maintaining a Hold rating.
Morgan Stanley
75p
Hold
27.01%
Upside
Reiterated
04/16/24
We think investors will be surprised by the extent of the downgrade, despite the series of guide downs the company has given over the past 18 months. We expect consensus to significantly de-risk 2025 forecasts on the back of the news, even with the company pointing to their guidance as a "worse case scenario". We cut our numbers in line with their worse case scenario guidance.
DOCS Analyst Recommendation Trends
Rating
May 24
Jun 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
7
8
5
5
4
Sell
3
2
1
0
0
Strong Sell
0
0
0
0
0
total
10
10
6
5
4
Each month's total comprises the sum of three months' worth of ratings.
DOCS Financial Forecast
DOCS Stock Forecast FAQ
What is GB:DOCS’s average 12-month price target, according to analysts?
Based on analyst ratings, Dr. Martens Plc’s 12-month average price target is 76.33p.
What is GB:DOCS’s upside potential, based on the analysts’ average price target?
Dr. Martens Plc has 29.26% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dr. Martens Plc a Buy, Sell or Hold?
Dr. Martens Plc has a consensus rating of Hold, which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
What is Dr. Martens Plc’s share price target?
The average share price target for Dr. Martens Plc is 76.33p. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 85.00p ,and the lowest forecast is 64.00p. The average share price target represents 29.26% Increase from the current price of 59.05p.
The highest analyst share price target is 85.00p ,and the lowest forecast is 64.00p. The average share price target represents 29.26% Increase from the current price of 59.05p.
What do analysts say about Dr. Martens Plc?
Dr. Martens Plc’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Dr. Martens Plc?
To buy shares of GB:DOCS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.